| 詳細情報 |   |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (138件)
- Erika Kitadai, Kakuhiro Yamaguchi, Hiroshi Iwamoto, Kiyofumi Shimoji, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Shinichiro Ohshimo, Hironobu Hamada, et al. Serum Soluble Toll-Like Receptor 4 is a Predictive Biomarker for Acute Exacerbation and Prognosis of Idiopathic Pulmonary Fibrosis: A Retrospective Study. Lung. 2025. 203. 1. 43-43
- Tetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi, Kiyofumi Shimoji, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Hiroshi Iwamoto, Hironobu Hamada, et al. Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer. Cancers. 2025
- Taku Nakashima. Lung cancer with comorbid interstitial pneumonia: Current situation and animal model development. Respiratory Investigation. 2024
- 福代 有希, 堀益 靖, 下地 清史, 山口 覚博, 坂本 信二郎, 檜垣 直子, 益田 武, 中島 拓, 岩本 博志, 濱田 泰伸, et al. 心嚢水を伴ったLoefgren症候群の1例. 日本サルコイドーシス/肉芽腫性疾患学会雑誌. 2024. 44. サプリメント号. 62-62
- 島田 俊宏, 岩本 博志, 下地 清史, 山口 覚博, 坂本 信二郎, 堀益 靖, 益田 武, 中島 拓, 濱田 泰伸, 服部 登. サルグラモスチム吸入療法を行った自己免疫性肺胞蛋白症の1例. 広島医学. 2024. 77. 10. 313-314
- Shugo Inada, Taku Nakashima, Takeshi Masuda, Kiyofumi Shimoji, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, et al. Sex-related differences in efficacy of bone marrow-derived high aldehyde dehydrogenase activity cells against pulmonary fibrosis. Stem cell research & therapy. 2024. 15. 1. 304-304
- Taku Nakashima. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Research. 2024. 25. 1
- 下地 清史, 中島 拓, 益田 武, 難波 将史, 坂本 信二郎, 山口 覚博, 堀益 靖, 見前 隆洋, 宮本 真太郎, 岩本 博志, et al. 腫瘍TR HIF-1αは間質性肺炎を介した肺がんの進行を調節する. 日本呼吸器学会誌. 2024. 13. 増刊. 185-185
- Miura, Shinichiro, Iwamoto, Hiroshi, Namba, Masashi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Ohshimo, Shinichiro, et al. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ OPEN RESPIRATORY RESEARCH. 2024. 11. 1
- Taku Nakashima. Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases. Internal Medicine. 2024
- Taku Nakashima. Primary pulmonary extranodal NK/T-cell lymphoma diagnosed by thoracoscopic lung biopsy: A case report. Respiratory Medicine Case Reports. 2024
- Shimoji, Kiyofumi, Nakashima, Taku, Masuda, Takeshi, Namba, Masashi, Sakamoto, Shinjiro, Yamaguchi, Kakuhiro, Horimasu, Yasushi, Mimae, Takahiro, Miyamoto, Shintaro, Iwamoto, Hiroshi, et al. Hypoxia-inducible factor 1a modulates interstitial pneumonia-mediated lung cancer progression. JOURNAL OF TRANSLATIONAL MEDICINE. 2023. 21. 1
- Taku Nakashima. Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis. Medicina. 2023. 59. 10
- Taku Nakashima. Intestinal overgrowth of Candida albicans exacerbates bleomycin-induced pulmonary fibrosis in mice with dysbiosis. The Journal of Pathology. 2023. 261. 2. 227-237
- Taku Nakashima. Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial-mesenchymal transition in lung endothelial cells. Cell Communication and Signaling. 2023. 21. 1
- Keitaro Omori, Hiroki Kitagawa, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, et al. Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan. Journal of Infection and Chemotherapy. 2023. 29. 9. 875-881
- Taku Nakashima. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases. Respiratory Medicine. 2023. 212
- Tanahashi, Hiroki, Yamaguchi, Kakuhiro, Kurose, Koji, Nakao, Satoshi, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, et al. Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis. RESPIROLOGY. 2023. 28. 4. 380-388
- Miura, Shinichiro, Iwamoto, Hiroshi, Omori, Keitaro, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Fujitaka, Kazunori, et al. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality. SCIENTIFIC REPORTS. 2023. 13. 1
- Tokumo, Kentaro, Masuda, Takeshi, Nakashima, Taku, Namba, Masashi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Miyamoto, Shintaro, Iwamoto, Hiroshi, Fujitaka, Kazunori, et al. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. CANCERS. 2023. 15. 4
前のページに戻る
